MedTrace Logo

PRogression of Atheroma Evaluated by CT Angiography and IntraCoronary Imaging tEchniques

NCT06794684 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2025-01-27

No results posted yet for this study

Summary

This is a combined cohort study with retrospectively and prospectively enrolled coronary artery disease (CAD) patients. All the patients will undergo clinical follow-up for up to 5 years, and repeat coronary CTA will be conducted after 2 years. Comprehensive morphological and functional plaque analysis will be performed. The impact of these morphological and functional parameters, alongside cardiometabolic factors and pharmacological treatments on plaque progression and the occurrence of major adverse cardiovascular events (MACEs) will be analyzed. In addition, intracoronary imaging techniques will be used to improve the accuracy of plaque analysis by coronary CTA.

Conditions

  • Coronary Arterial Disease (CAD)
  • Coronary Arteriosclerosis

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Principal Investigators

  • Ruiyan Zhang, M.D., Ph.D. · Ruijin Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2027-05-31
Completion
2030-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06794684 on ClinicalTrials.gov